Locations:
Search
In the Cleveland Clinic Innovations profile series, members of the Innovations team share their journey to joining the Innovations department at Cleveland Clinic, what they find inspiring about their role, and what innovation means to them.
Cleveland Clinic recognized as one of the most innovative health systems.
Dr. Margot Damaser’s new device improves on her “Fitness tracker for the bladder” and measures both pressure and volume in preclinical models. Her milestone 200th paper was published in IEEE Sensors Journal. The Urodynamics Monitor (UM) was developed with support from Cleveland Clinic Innovations.
Company currently collaborates with Cleveland Clinic on breast cancer and ovarian cancer vaccines. The research under the new joint development agreement will be led at Cleveland Clinic by Thaddeus Stappenbeck, MD, PhD, Department Chair of Inflammation and Immunity.
The initial product launch reveals significant financial benefits for payers and providers.
Clario and Cleveland Clinic's Cole Eye Institute announce strategic partnership to provide new ophthalmology offerings for clinical trials.
NeuroTherapia, a Cleveland Clinic Innovations portfolio company, has been awarded its second grant from the Alzheimer's Association Part the Cloud program. The grant will fund the clinical development of NTRX-07, a first-of-its-kind drug for Alzheimer's disease (AD) treatment.
Cleveland Clinic Innovations leaders share insights into the digital technologies currently transforming the healthcare industry. Facing unprecedented challenges, including escalating operational costs and severe workforce shortages, these pioneering technologies are proving essential, delivering practical solutions that enhance efficiency and patient care.
Cleveland Clinic Magazine highlights innovation through three successful startups, Zehna Therapeutics, Method AI, and Mobius Care, that are impacting patient care
Cleveland Clinic invested in the startup company, Floreo who has acquired Autism Eyes, an autism diagnostics and assessment company that Cleveland Clinic spun off in 2019. JD Friedland, Managing Director of Cleveland Clinic Ventures, discusses the significant contributions these companies are making to autism research